ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), the medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that it is scheduled to present at the Brean Murray, Carret & Co. 2007 Small-Cap Healthcare & Biotechnology One-on-One Conference. The event will be held on Tuesday, May 15, 2007 in New York City. The presentation will not be webcast, however, the slides used for this presentation will be available beginning May 14, 2007 on the “Investors” section of BioSphere Medical’s website at : www.biospheremed.com.
